Enzo Biochem, Inc.
(NYSE : ENZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.01%152.520.0%$4782.73m
NVAXNovavax, Inc. -2.25%126.2592.9%$675.98m
BNTXBioNTech SE 1.11%120.000.0%$672.24m
AMGNAmgen, Inc. 1.01%229.211.3%$578.56m
GILDGilead Sciences, Inc. 1.15%61.561.0%$506.97m
BIIBBiogen, Inc. 0.73%245.871.7%$496.02m
REGNRegeneron Pharmaceuticals, Inc. -1.28%492.452.7%$472.10m
VRTXVertex Pharmaceuticals, Inc. 0.64%228.321.9%$455.95m
ILMNIllumina, Inc. 1.35%350.663.5%$426.07m
EXASEXACT Sciences Corp. 1.68%132.8719.6%$207.83m
SGENSeagen Inc. -0.52%179.235.8%$156.07m
BGNEBeiGene Ltd. 0.71%222.881.4%$141.27m
CRSPCRISPR Therapeutics AG 5.04%147.540.6%$137.84m
TXG10X Genomics, Inc. 2.63%149.040.0%$136.40m
SRNESorrento Therapeutics, Inc. 0.00%7.971.4%$136.15m

Company Profile

Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.